Because both SLC30A10 Thr95Ile and extrahepatic bile duct cancer are exceedingly rare, validation of this association in either another very large biobank or in a cohort of cholangiocarcinoma patients will be necessary. This evidence concerns the gene SLC30A10 and extrahepatic bile duct carcinoma.